Role of MicroRNAs in Lung Disease;Rol de los microARN en las enfermedades pulmonares

Archivos de Bronconeumologia

Volumn 48, Issue 9, 2012, Pages 325-330

  Angulo, Martín ^a,b   Lecuona, Emilia ^a   Sznajder, Jacob Iasha ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Lung cancer; Lung disease; Lung injury; MicroRNA; Pulmonary fibrosis; Smoking

Indexed keywords

MICRORNA;

GENE FUNCTION; HUMAN; LUNG DISEASE; PATHOGENESIS; SHORT SURVEY;

EID: 84864832116     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2012.06.015     Document Type: Short Survey

References (76)

1. Nana-Sinkam S.P., Hunter M.G., Nuovo G.J., Schmittgen T.D., Gelinas R., Galas D., et al. Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med 2009, 179:4-10.
2. Tomankova T., Petrek M., Kriegova E. Involvement of microRNAs in physiological and pathological processes in the lung. Respir Res 2010, 11:159.
3. Zhou T., Garcia J.G., Zhang W. Integrating microRNAs into a system biology approach to acute lung injury. Transl Res 2011, 157:180-190.
4. Oglesby I.K., McElvaney N.G., Greene C.M. MicroRNAs in inflammatory lung disease--master regulators or target practice?. Respir Res 2010, 11:148.
5. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011, 91:827-887.
6. Pagdin T., Lavender P. MicroRNAs in lung diseases. Thorax 2012, 67:183-184.
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Lee R.C., Feinbaum R.L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
9. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157.
10. Ender C., Meister G. Argonaute proteins at a glance. J Cell Sci 2010, 123:1819-1823.
11. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
12. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
13. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
14. Hergenreider E., Heydt S., Treguer K., Boettger T., Horrevoets A.J., Zeiher A.M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14:249-256.
15. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 2012, 22:125-132.
16. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J Biochem 2010, 148:381-392.
17. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
18. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358.
19. Karreth F.A., Tay Y., Perna D., Ala U., Tan S.M., Rust A.G., et al. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011, 147:382-395.
20. The facts about smoking and health. World Health Organization Fact sheets 2006, World Health Organization.
21. Gower A.C., Steiling K., Brothers J.F., Lenburg M.E., Spira A. Transcriptomic studies of the airway field of injury associated with smoking-related lung disease. Proc Am Thorac Soc 2011, 8:173-179.
22. Izzotti A., Calin G.A., Arrigo P., Steele V.E., Croce C.M., De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009, 23:806-812.
23. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 2009, 106:2319-2324.
24. Davidson M.R., Larsen J.E., Yang I.A., Hayward N.K., Clarke B.E., Duhig E.E., et al. MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 2010, 5:e12560.
25. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
26. Van Pottelberge G.R., Mestdagh P., Bracke K.R., Thas O., Durme Y.M., Joos G.F., et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 183:898-906.
27. Soriano J.B., Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc 2011, 8:363-367.
28. Sato T., Liu X., Nelson A., Nakanishi M., Kanaji N., Wang X., et al. Reduced miR-146a increases prostaglandin Ein chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010, 182:1020-1029.
29. Koshiol J., Rotunno M., Consonni D., Pesatori A.C., De Matteis S., Goldstein A.M., et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 2009, 4:e7380.
30. Ezzie M.E., Crawford M., Cho J.H., Orellana R., Zhang S., Gelinas R., et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2012, 67:122-131.
31. Maltais F., LeBlanc P., Whittom F., Simard C., Marquis K., Belanger M., et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000, 55:848-853.
32. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
33. Fermoselle C., Rabinovich R., Ausin P., Puig-Vilanova E., Coronell C., Sanchez F., et al. Does oxidative stress modulate limb muscle atrophy in severe copd patients? [en prensa]. Eur Respir J 2012.
34. Lewis A., Riddoch-Contreras J., Natanek S.A., Donaldson A., Man W.D., Moxham J., et al. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 2012, 67:26-34.
35. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
36. Miller Y.E. Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 2005, 33:216-223.
37. Lin P.Y., Yu S.L., Yang P.C. MicroRNA in lung cancer. Br J Cancer 2010, 103:1144-1148.
38. Liu X., Sempere L.F., Guo Y., Korc M., Kauppinen S., Freemantle S.J., et al. Involvement of microRNAs in lung cancer biology and therapy. Transl Res 2011, 157:200-208.
39. Karube Y., Tanaka H., Osada H., Tomida S., Tatematsu Y., Yanagisawa K., et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005, 96:111-115.
40. Hayashita Y., Osada H., Tatematsu Y., Yamada H., Yanagisawa K., Tomida S., et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005, 65:9628-9632.
41. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010, 120:1298-1309.
42. Seike M., Goto A., Okano T., Bowman E.D., Schetter A.J., Horikawa I., et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009, 106:12085-12090.
43. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
44. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
45. Liu X., Sempere L.F., Galimberti F., Freemantle S.J., Black C., Dragnev K.H., et al. Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 2009, 15:1177-1183.
46. Gallardo E., Navarro A., Vinolas N., Marrades R.M., Diaz T., Gel B., et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009, 30:1903-1909.
47. Nasser M.W., Datta J., Nuovo G., Kutay H., Motiwala T., Majumder S., et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 2008, 283:33394-33405.
48. Crawford M., Batte K., Yu L., Wu X., Nuovo G.J., Marsh C.B., et al. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 2009, 388:483-489.
49. Skrzypski M., Dziadziuszko R., Jassem J. MicroRNA in lung cancer diagnostics and treatment. Mutat Res 2011, 717:25-31.
50. Yu L., Todd N.W., Xing L., Xie Y., Zhang H., Liu Z., et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010, 127:2870-2878.
51. Xing L., Todd N.W., Yu L., Fang H., Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010, 23:1157-1164.
52. Lodes M.J., Caraballo M., Suciu D., Munro S., Kumar A., Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009, 4:e6229.
53. Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
54. Raponi M., Dossey L., Jatkoe T., Wu X., Chen G., Fan H., et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009, 69:5776-5783.
55. Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010, 28:1721-1726.
56. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
57. King T.E., Pardo A., Selman M. Idiopathic pulmonary fibrosis. Lancet 2011, 378:1949-1961.
58. Pandit K.V., Corcoran D., Yousef H., Yarlagadda M., Tzouvelekis A., Gibson K.F., et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010, 182:220-229.
59. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007, 293:L525-L534.
60. Liu G., Friggeri A., Yang Y., Milosevic J., Ding Q., Thannickal V.J., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010, 207:1589-1597.
61. Yang S., Banerjee S., de Freitas A., Sanders Y.Y., Ding Q., Matalon S., et al. Participation of miR-200 in Pulmonary Fibrosis. Am J Pathol 2012, 180:484-493.
62. Cushing L., Kuang P.P., Qian J., Shao F., Wu J., Little F., et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011, 45:287-294.
63. Pandit K.V., Milosevic J., Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011, 157:191-199.
64. Pottier N., Maurin T., Chevalier B., Puissegur M.P., Lebrigand K., Robbe-Sermesant K., et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009, 4:e6718.
65. Wheeler A.P., Bernard G.R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564.
66. Cai Z.G., Zhang S.M., Zhang Y., Zhou Y.Y., Wu H.B., Xu X.P. MicroRNAs are dynamically regulated and play an important role in LPS-induced lung injury. Can J Physiol Pharmacol 2012, 90:37-43.
67. Xie T., Liang J., Liu N., Wang Q., Li Y., Noble P.W., et al. MicroRNA-127 Inhibits Lung Inflammation by Targeting IgG Fcgamma Receptor I. J Immunol 2012, 188:2437-2444.
68. Vadasz I., Hubmayr R.D., Nin N., Sporn P.H., Sznajder J.I. Hypercapnia - a Non-permissive Environment for the Lung. Am J Respir Cell Mol Biol 2012, 46:417-421.
69. Vohwinkel C.U., Lecuona E., Sun H., Sommer N., Vadasz I., Chandel N.S., et al. Elevated CO(2) levels cause mitochondrial dysfunction and impair cell proliferation. J Biol Chem 2011, 286:37067-37076.
70. O'Toole D., Hassett P., Contreras M., Higgins B.D., McKeown S.T., McAuley D.F., et al. Hypercapnic acidosis attenuates pulmonary epithelial wound repair by an NF-kappaB dependent mechanism. Thorax 2009, 64:976-982.
71. Wang G., Mao W., Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 2008, 582:3663-3668.
72. Locksley R.M. Asthma and allergic inflammation. Cell 2010, 140:777-783.
73. Lu T.X., Munitz A., Rothenberg M.E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009, 182:4994-5002.
74. Mattes J., Collison A., Plank M., Phipps S., Foster P.S. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 2009, 106:18704-18709.
75. Chiba Y., Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci 2010, 114:264-268.
76. Williams A.E., Larner-Svensson H., Perry M.M., Campbell G.A., Herrick S.E., Adcock I.M., et al. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009, 4:e5889.